MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Familial neurodegenerative diseases"

  • 2025 International Congress

    Case Report of a Brazilian Family With New VUS for PLAN

    M. Medeiros, M. Augustin (Porto Alegre, Brazil)

    Objective: The aim is to describe a Brazilian family with new VUS of PLA2G6 in two brothers with clinical symptoms of PLAN. Background: PLAN is…
  • 2025 International Congress

    Parkinson’s disease (PD) associated with the E46K mutation in the SNCA gene, twenty years after

    B. Tijero Merino, MA. Acera Gil, I. Gabilondo, T. Fernandez Valle, M. Ruiz Lopez, R. Sanchez Pernaute, A. Murueta-Goyena, I. Diez, C. Juanes, R. Del Pino, N. Ayo-Mentxakatorre, JC. Gomez-Esteban (Barakaldo, Spain)

    Objective: To provide an updated overview of Parkinson’s disease (PD) associated with E46K mutation carriers in the SNCA gene 20 years after its description, incorporating…
  • 2024 International Congress

    Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

    M. Lai, B. Benitez (Boston, USA)

    Objective: Integrate proteomics from the cerebrospinal fluid (CSF) and urine from the Parkinson’s Progression Markers Initiative cohort to prioritize the risk variants associated with Parkinson’s…
  • 2024 International Congress

    Can Heterozygous Autosomal Recessive Mutations Cause Neurological Disease?

    L. Patil, M. Bhatt (Mumbai, India)

    Objective: To highlight the significance of heterozygous PLA2G6 and PRKN gene mutations in causing parkinsonism. Background: We report our observations in two families with multiple…
  • 2024 International Congress

    Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

    R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)

    Objective: This project aimed to characterize the first-ever transgenic ATP13A2 knockout rat model to elucidate the underlying mechanisms of ATP13A2-associated pathology. Background: Most Parkinson’s disease…
  • 2024 International Congress

    Perry Syndrome due to a DCTN1 novel variant

    P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

    Objective: To report the clinical features of a patient with Perry syndrome (PS) due to a heterozygous novel pathogenic variant in the DCTN1 gene. Background:…
  • 2024 International Congress

    Territorial inventory of training needs in nursing home for the support of patients with Parkinson’s syndrome

    J. Thezenas (Eaubonne, France)

    Objective: - Raise awareness among the various professionals in contact with patients suffering from Parkinson's syndromes- Optimize follow-up and support- Avoid emergency room visits through…
  • 2024 International Congress

    Utility of Instrumented Timed Up and Go Test to Estimate Disease Severity in Huntington Disease.

    D. Wani, M. Lin, C. Macpherson, T. Ravikumar, M. Campbell, L. Muratori, N. Fritz, L. Quinn (New York, USA)

    Objective: To investigate the utility of Instrumented Timed Up and Go (TUG) test to estimate disease severity in people with Huntington Disease (PwHD). Background: Huntington…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 2024 International Congress

    Spinocerebellar Ataxia Type 4: a Novel Polyglycine Disease caused by GGC Repeat Expansion in ZFHX3.

    S. Pulst (slc, USA)

    Objective: Identification of the mutation causing SCA4. Background: SCA4 is an autosomal dominant disease, originally described in a large Utah pedigree, characterized by sensory and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley